Immerse yourself in a world of knowledge and creativity with every page turn.

Immerse yourself in a world of knowledge and creativity with every page turn.

Immerse yourself in a world of knowledge and creativity with every page turn.

/

/

Share this news:

Share this news:

Protein Linked to Sudden Cardiac Death After Heart Attacks, Study Finds

Protein Linked to Sudden Cardiac Death After Heart Attacks, Study Finds

Massachusetts General Hospital researchers have found that the immune protein RELMγ can trigger deadly heart arrhythmias post-heart attack, opening a potential new preventive treatment path.

High-quality image of a stylized heartbeat visual, suitable for illustrating cardiovascular research or heart-related medical findings.

Source:

Medical Xpress

New Link Between Immunity and Heart Risks

Scientists at Massachusetts General Hospital have uncovered a surprising immune mechanism behind sudden cardiac death after heart attacks. The culprit is an immune protein Resistin-like molecule gamma (RELMγ), produced by white blood cells called neutrophils.

HowREL Gγ Works

  • Following heart attacks, neutrophils flood the heart and secrete RELMγ.

  • The protein punches holes in heart cells, disrupting their electrical signals.

  • This process can trigger dangerous arrhythmias like ventricular tachycardia (VT) and ventricular fibrillation (VF).

This discovery, published in Science, reveals how inflammation can directly cause lethal rhythm disturbances in the heart.

Keep up with the story. Subscribe to the PR+ free daily newsletter

Computer-generated wireframe image representing heart health and cardiology technologies.

Source:

ScienceDaily

Experimental Breakthrough in Mice

Genetically removing RELMγ in mice cut the rate of deadly heart arrhythmias twelvefold, researchers report. Visual evidence from Science includes electron microscopy showing the holes RELMγ creates in cell membranes.

Clinical Implications

  • Human samples also indicate elevated resistin proteins in post-heart attack hearts.

  • Currently, arrhythmia prevention relies on devices and emergency defibrillation, with few preventive therapies.

  • Targeting RELMγ could mark a substantial shift toward immune-based arrhythmia prevention.

Dramatic image of a man clutching his chest, often used to depict the sudden onset of a heart attack.

Source:

SciTechDaily

Outlook and Next Steps

The research team is now developing inhibitors to block RELMγ's cell-damaging action. Human clinical trials will be the next major milestone.

Why It Matters

  • This finding could lead to new therapies for an estimated 800,000 Americans who suffer heart attacks each year.

  • Experts believe this mechanism may apply to other inflammatory diseases affecting the heart.

“This immune protein is a game-changer in our understanding of sudden cardiac death,” lead authors noted in press materials.

Outlook and Next Steps

The research team is now developing inhibitors to block RELMγ's cell-damaging action. Human clinical trials will be the next major milestone.

Why It Matters

  • This finding could lead to new therapies for an estimated 800,000 Americans who suffer heart attacks each year.

  • Experts believe this mechanism may apply to other inflammatory diseases affecting the heart.

“This immune protein is a game-changer in our understanding of sudden cardiac death,” lead authors noted in press materials.

How does Resistin-like molecule gamma specifically attack heart cells?

RELMγ, produced by neutrophils after a heart attack, binds to heart cell membranes and forms holes, weakening cellular structure and disrupting electrical activity, which can cause arrhythmias.

How does Resistin-like molecule gamma specifically attack heart cells?

RELMγ, produced by neutrophils after a heart attack, binds to heart cell membranes and forms holes, weakening cellular structure and disrupting electrical activity, which can cause arrhythmias.

How does Resistin-like molecule gamma specifically attack heart cells?

RELMγ, produced by neutrophils after a heart attack, binds to heart cell membranes and forms holes, weakening cellular structure and disrupting electrical activity, which can cause arrhythmias.

What are the potential therapeutic avenues for targeting Resistin-like molecule gamma?

What are the potential therapeutic avenues for targeting Resistin-like molecule gamma?

What are the potential therapeutic avenues for targeting Resistin-like molecule gamma?

How does the removal of Resistin-like molecule gamma in mice reduce ventricular arrhythmias?

How does the removal of Resistin-like molecule gamma in mice reduce ventricular arrhythmias?

How does the removal of Resistin-like molecule gamma in mice reduce ventricular arrhythmias?

What role do neutrophils play in the development of arrhythmias after a heart attack?

What role do neutrophils play in the development of arrhythmias after a heart attack?

What role do neutrophils play in the development of arrhythmias after a heart attack?

Are there any human studies or clinical trials planned to test the effects of targeting Resistin-like molecule gamma?

Are there any human studies or clinical trials planned to test the effects of targeting Resistin-like molecule gamma?

Are there any human studies or clinical trials planned to test the effects of targeting Resistin-like molecule gamma?

Share this news: